Advanced search
Publication Cover
Emerging Microbes & Infections Volume 7, 2018 - Issue 1
Submit an article Journal homepage
1,914
Views
19
CrossRef citations to date
0
Altmetric
Original Articles

Upregulation of HBV transcription by sodium taurocholate cotransporting polypeptide at the postentry step is inhibited by the entry inhibitor Myrcludex B

Kaitao ZhaoState Key Laboratory of Virology, Wuhan Institute of VirologyChinese Academy of Sciences430071WuhanChina;University of Chinese Academy of Sciences100049BeijingChina
,
Shuhui LiuState Key Laboratory of Virology, Wuhan Institute of VirologyChinese Academy of Sciences430071WuhanChina;University of Chinese Academy of Sciences100049BeijingChina
,
Yingshan ChenState Key Laboratory of Virology, Wuhan Institute of VirologyChinese Academy of Sciences430071WuhanChina;University of Chinese Academy of Sciences100049BeijingChina
,
Yongxuan YaoState Key Laboratory of Virology, Wuhan Institute of VirologyChinese Academy of Sciences430071WuhanChina;University of Chinese Academy of Sciences100049BeijingChina
,
Ming ZhouShenzhen Xenotransplantation Research and Development Center, State and Local Joint Cancer Genome Clinical Application of Key Technology Laboratory, Shenzhen Second People’s HospitalFirst Affiliated Hospital of Shenzhen University518035ShenzhenChina
,
Yifei YuanState Key Laboratory of Virology, Wuhan Institute of VirologyChinese Academy of Sciences430071WuhanChina;University of Chinese Academy of Sciences100049BeijingChina
,
Yun WangState Key Laboratory of Virology, Wuhan Institute of VirologyChinese Academy of Sciences430071WuhanChina
,
Rongjuan PeiState Key Laboratory of Virology, Wuhan Institute of VirologyChinese Academy of Sciences430071WuhanChina
,
Jizheng ChenState Key Laboratory of Virology, Wuhan Institute of VirologyChinese Academy of Sciences430071WuhanChina
,
Xue HuState Key Laboratory of Virology, Wuhan Institute of VirologyChinese Academy of Sciences430071WuhanChina
,
Yuan ZhouState Key Laboratory of Virology, Wuhan Institute of VirologyChinese Academy of Sciences430071WuhanChina
,
He ZhaoState Key Laboratory of Virology, Wuhan Institute of VirologyChinese Academy of Sciences430071WuhanChina
,
Mengji LuInstitute of VirologyUniversity Hospital of Essen45147EssenGermany
,
Chunchen WuState Key Laboratory of Virology, Wuhan Institute of VirologyChinese Academy of Sciences430071WuhanChinaCorrespondence[email protected]
&
Xinwen ChenState Key Laboratory of Virology, Wuhan Institute of VirologyChinese Academy of Sciences430071WuhanChina;University of Chinese Academy of Sciences100049BeijingChinaCorrespondence[email protected]
 show all
Pages 1-14 | Received 04 Jul 2018, Accepted 26 Oct 2018, Published online: 21 Nov 2018

References

  • OttJJStevensGAGroegerJWiersmaSTGlobal epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicityVaccine201230 2212 221910.1016/j.vaccine.2011.12.116
  • RenXHepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosisJ. Viral Hepat.20101788789510.1111/j.1365-2893.2009.01254.x
  • PetersenJThompsonAJLevreroMAiming for cure in HBV and HDVinfectionJ. Hepat.20166583584810.1016/j.jhep.2016.05.043
  • YanHSodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D viruseLife20121e0004910.7554/eLife.00049
  • UrbanSBartenschlagerRKubitzRZoulimFStrategies to inhibit entry of HBV and HDV into hepatocytesGastroenterology2014147486410.1053/j.gastro.2014.04.030
  • SchulzeASchieckANiYMierWUrbanSFine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interactionJ. Virol.2010841989200010.1128/JVI.01902-09
  • LutgehetmannMHumanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluationHepatology20125568569410.1002/hep.24758
  • VolzTThe entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis BvirusJ. Hepat.20135886186710.1016/j.jhep.2012.12.008
  • BlankAFirst-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex BJ. Hepat.20166548348910.1016/j.jhep.2016.04.013
  • BogomolovPTreatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa studyJ. Hepat.20166549049810.1016/j.jhep.2016.04.016
  • AnwerMSStiegerBSodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transportersPflug. Arch.2014466778910.1007/s00424-013-1367-0
  • TraunerMTargeting nuclear bile acid receptors for liver diseaseDig. Dis.2011299810210.1159/000324141
  • RamiereCTransactivation of the hepatitis B virus core promoter by the nuclear receptor FXRalphaJ. Virol.200882108321084010.1128/JVI.00883-08
  • LiJUnusual features of sodium taurocholate cotransporting polypeptide as a hepatitis B virus receptorJ. Virol.2016908302831310.1128/JVI.01153-16
  • YanHViral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptideJ. Virol.2014883273328410.1128/JVI.03478-13
  • LiWHUrbanSEntry of hepatitis B and hepatitis D virus into hepatocytes: basic insights and clinical implicationsJ. Hepat.201664S32S4010.1016/j.jhep.2016.02.011
  • KonigAKinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytesJ. Hepat.20146186787510.1016/j.jhep.2014.05.018
  • ZhongGSodium taurocholate cotransporting polypeptide mediates woolly monkey hepatitis B virus infection of Tupaia hepatocytesJ. Virol.2013877176718410.1128/JVI.03533-12
  • YanHMolecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptideJ. Virol.2013877977799110.1128/JVI.03540-12
  • HuangLRWuHLChenPJChenDSAn immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infectionProc. Natl Acad. Sci. USA2006103178621786710.1073/pnas.0608578103
  • ParksDJBile acids: natural ligands for an orphan nuclear receptorScience19992841365136810.1126/science.284.5418.1365
  • MakishimaMIdentification of a nuclear receptor for bile acidsScience19992841362136510.1126/science.284.5418.1362
  • WagnerMZollnerGTraunerMNuclear receptor regulation of the adaptive response of bile acid transporters in cholestasisSemin. Liver. Dis.20103016017710.1055/s-0030-1253225
  • RenJHSirtuin 1 regulates hepatitis B virus transcription and replication by targeting transcription factor AP-1J. Virol.2014882442245110.1128/JVI.02861-13
  • QuasdorffMProtzerUControl of hepatitis B virus at the level of transcriptionJ. Viral Hepat.20101752753610.1111/j.1365-2893.2010.01315.x
  • Lempp, F. A. & Urban, S. Hepatitis delta virus: replication strategy and upcoming therapeutic options for a neglected human pathogen. Viruses9, pii: E172 (2017).
  • RadeloffDMale suicide rates in German prisons and the role of citizenshipPLoS One201712e017895910.1371/journal.pone.0178959
  • KemperJKFXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease statesCell. Metab.20091039240410.1016/j.cmet.2009.09.009
  • DengJJInterplay between SIRT1 and hepatitis B virus X protein in the activation of viral transcriptionBiochim Biophys. Acta Gene Regul. Mech.2017186049150110.1016/j.bbagrm.2017.02.007
  • CurtilCThe metabolic sensors FXRalpha, PGC-1alpha, and SIRT1 cooperatively regulate hepatitis B virus transcriptionFASEB J.2014281454146310.1096/fj.13-236372
  • Van DykeRWStephensJEScharschmidtBFBile acid transport in cultured rat hepatocytesAm. J. Physiol.1982243G484G492
  • MitaSVectorial transport of unconjugated and conjugated bile salts by monolayers of LLC-PK1 cells doubly transfected with human NTCP and BSEP or with rat Ntcp and BsepAm. J. Physiol. Gastrointest. Liver Physiol.2006290G550G55610.1152/ajpgi.00364.2005
  • GriponPCannieIUrbanSEfficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface proteinJ. Virol.2005791613162210.1128/JVI.79.3.1613-1622.2005
  • HaagMQuantitative bile acid profiling by liquid chromatography quadrupole time-of-flight mass spectrometry: monitoring hepatitis B therapy by a novel Na(+)-taurocholate cotransporting polypeptide inhibitorAnal. Bioanal. Chem.20154076815682510.1007/s00216-015-8853-5
  • ZhouMRevival, characterization, and hepatitis B virus infection of cryopreserved human fetal hepatocytesJ. Virol. Methods2014207293710.1016/j.jviromet.2014.06.015
  • ZhaoKCeruloplasmin inhibits the production of extracellular hepatitis B virions by targeting its middle surface proteinJ. Gen. Virol.2017981410142110.1099/jgv.0.000708
  • ZhouMProductive HBV infection of well-differentiated, hNTCP-expressing human hepatoma-derived (Huh7) cellsVirol. Sin.20173246547510.1007/s12250-017-3983-x
  • CaoLCoexistence of hepatitis B virus quasispecies enhances viral replication and the ability to induce host antibody and cellular immune responsesJ. Virol.2014888656866610.1128/JVI.01123-14
  • LiuSMITA/STING and its alternative splicing isoform MRP restrict hepatitis B virus replicationPLoS One201712e016970110.1371/journal.pone.0169701

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.